|
DGAP-Ad-hoc: JENOPTIK AG / Key word(s): Takeover Jenoptik strengthens global photonics business with the acquisition of Berliner Glas Medical and SwissOptic JENOPTIK AG (FSE: JEN / ISIN: DE000A2NB601) is set to acquire from Berliner Glas GmbH, a wholly-owned subsidiary of ASML Holding N.V., a 100 percent stake in BG Medical Applications GmbH ("Berliner Glas Medical"), a supplier of high-precision, custom optical components for the medical technology sector based in Berlin, as well as SwissOptic AG, a specialist in the development and manufacture of optical components and assemblies, primarily for the medical technology, semiconductor, and metrology industries headquartered in Heerbrugg/Switzerland, and the Chinese company SwissOptic (Wuhan) Co., Ltd., based in Wuhan/China. The purchase price amounts to around 300 million euros. In 2022, the acquired companies are expected to contribute approximately 130 million euros in revenue. In the coming years, a revenue growth rate in the low double-digit percentage range with an attractive margin profile is expected. The acquisition has already been approved by the JENOPTIK AG Supervisory Board, and is subject to the approval from the German Federal Cartel Office (Bundeskartellamt). Closing is expected for December 2021. If you have any further questions, please contact:
Contact: Leslie Iltgen Vice President Investor Relations & Communications Phone 03641-652291
19-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | JENOPTIK AG |
| Carl-Zeiss-Straße 1 | |
| 07743 Jena | |
| Germany | |
| Phone: | +49 (0)364 165-2156 |
| Fax: | +49 (0)364 165-2804 |
| E-mail: | ir@jenoptik.com |
| Internet: | www.jenoptik.com |
| ISIN: | DE000A2NB601 |
| WKN: | A2NB60 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1241812 |
| End of Announcement | DGAP News Service |
|
|
1241812 19-Oct-2021 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
